Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹241 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹241 Cr
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹241 Cr
-13.91
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,026.4 Cr -11.4% -9.8% -32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-11.4%

-9.8%

-32.6%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses